CLINICAL_TRIALS
trial_result
· 2024-12-11
Clinical Trial Update: Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
Summary
Completion of a National Cancer Institute–sponsored needs assessment study examining the needs of individuals and families affected by Dyskeratosis Congenita an…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Dyskeratosis Congenita, Telomere Biology Disorders | Status: COMPLETED